Patents by Inventor Thomas E. Stumpfig

Thomas E. Stumpfig has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Spray-dried formulation of a pyridazinone TRPC5 inhibitor
    Patent number: 12576033
    Abstract: Disclosed are spray-dried formulations of 4-chloro-5-(4-(4-fluoro-2-(trifluoromethyl)phenoxy)-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl)pyridazin-3(2H)-one, methods and compositions for making the same, and solid dosage forms comprising the same. The dosage forms described herein are useful in methods of treating kidney diseases or neuropathies associated with diseases or conditions, and in methods of treating pain, anxiety, or depression.
    Type: Grant
    Filed: April 10, 2020
    Date of Patent: March 17, 2026
    Assignee: GFB (ABC), LLC
    Inventors: Donald T. Corson, Elizabeth Chu Kwong, Thomas E. Stumpfig, Daniel T. Smithey, Erica B. Schlesinger
  • SPRAY-DRIED FORMULATION OF A PYRIDAZINONE TRPC5 INHIBITOR
    Publication number: 20220183981
    Abstract: Disclosed are spray-dried formulations of 4-chloro-5-(4-(4-fluoro-2-(trifluoromethyl)phenoxy)-5,8-dihydropyrido[3,4-d]pyrimidin-7(6H)-yl)pyridazin-3(2H)-one, methods and compositions for making the same, and solid dosage forms comprising the same. The dosage forms described herein are useful in methods of treating kidney diseases or neuropathies associated with diseases or conditions, and in methods of treating pain, anxiety, or depression.
    Type: Application
    Filed: April 10, 2020
    Publication date: June 16, 2022
    Inventors: Donald T. Corson, Elizabeth Chu Kwong, Thomas E. Stumpfig, Daniel T. Smithey, Erica B. Schlesinger